• CORE TECHNOLOGY
  • APPLICATIION
  • PRODUTION CAPACITY

CORE TECHNOLOGY


FIFTH GENERATION  CTC Tech



Based on the difference in sugar metabolism between cancer cells and normal cells,

the fifth generation of CTC technology is produced by cross-border technology innovation.


The CTC capture capability is increased by more than 10 times,

solving many shortcomings of traditional CTC detection technology,

such as low detection rate, no cell activity, and false negatives and false positives.

TESTING PROCESS

After the sample is received, the blood sample will be pre-processed,

the target cells will be captured by nanoprobes, the slides will be stained,

the microscopic examination will be interpreted, the results will be reviewed, and the report will be issued.

Only takes 2 hours to complete the testing process of a single project,

and the general report can be issued within 3 working days after the sample is received.

CLINICAL VALIDATION

After multi-center clinical verification,

the overall sensitivity and specificity of the technology have reached more than 90%.

The clinical samples cover multiple common cancers such as lung cancer,

liver cancer, colorectal cancer, breast cancer, and gastric cancer, including different stage types I-IV.

In addition, we conducted a horizontal comparison with third-party evaluation technology.
In comparison, this evaluation technology has obvious advantages in detection sensitivity and detection quantity.

APPLICABLE USER

Malignant Disease
Suspected Tumor Patients
Tumor Patients Undergoing Surgery
Tumor Patients Undergoing Drug Therapy
Malignant Tumor Recovery Crowd
Health Managemant
Health Preservation People
Smokers & Drinkers
High-pressure & high-risk people
Benign Diseases
Nodules Patients
Hyperplasia Datients
Chronic Inflammation Patients
Chronic Diseases Patients

APPLICATION EXPANSION



It can be applied to the entire cycle of tumor diagnosis and treatment,

including early screening, auxiliary diagnosis, efficacy prediction, recurrence warning and prognosis evaluation.

It can guide the health management of healthy people and prevent problems before they happen.

It can also predict the disease risk of patients with benign lesions,

detect malignant lesions early, and achieve early detection, early diagnosis and early treatment.

It can also guide the personalized treatment and recurrence risk warning of tumor patients,

understand the dynamic changes of patients' tumors in real time, intervene in time,

save time and cost, and improve the accuracy of treatment.

  • Healthy Cells
  • Canceration
  • Malignant Lesions
  • Tumor Metastasis


Monitoring and evaluating the changes in the number and physiological characteristics of CTC
can help us understand the occurrence and progression of tumors in a timely and effective manner.

Therefore, CTC can not only be used to guide patients' response to drugs and warn of recurrence risks,
but also serve as a window to understand the molecular mechanisms of tumor pathogenicity
and drug resistance mechanisms.


A large number of studies have confirmed the effectiveness of CTC in tumor prognosis assessment,
efficacy prediction, and recurrence assessment.
CTC have also entered multiple global diagnosis and treatment guidelines and expert consensuses,
and have been recognized and paid attention to by more and more clinical experts.
CTC are important prognostic markers for multiple solid tumors
such as breast cancer, colorectal cancer, and prostate cancer.

SIX ADVANTAGE


Detect More
More than 100 known
cancers and leukemias
can be detected
High Accuracy
Sensitivity 91.96%, specificity 96.56%
User Friendly
Only collect blood, low risk and no radiation
FAST Detection
Only 2 hours for report
Auxiliary Diagnosis
Diagnosis based on evidence,efficacy can be verified
Dynamic Monitoring
Accept multiple high-frequency & dynamic tracking detection

Production Environment


  • Clean Production Area
    Clean Production Area
    It uses advanced air purification systems and aseptic technology to ensure the cleanliness and sterility of the production environment.
    To ensure the quality and safety of the product.
  • Water Purification Room
    Water Purification Room
    Responsible for water quality testing and treatment. The production of reagents Requires very high water quality.
    We have used advanced water purification equipment and technology to reduce impurities and ensure the purity and sterility of production water.
  • Inspection And Testing Room
    Inspection And Testing Room
    Responsible for product quality inspection and testing. We are very strict with every inspection and testing of our products.
    Ensure that the product complies with relevant standards.
  • Air Conditioning Equipment Room
    Air Conditioning Equipment Room
    It advanced technology and equipment to ensure the safety, efficiency, and stability of the production process.

Research And Develpment Process

After 12 years of research and development, we have successfully produced this Multi-cancer Detetion System.

It has been validated through over 10000 clinical samples.


Compared with existing CTC detection technologies,

the Fifth Generation CTC Tech has improved CTC capture level by more than 10 times,

with a sensitivity of up to 92% and specificity of over 96.5%.


It is suitable for CTC indicator evaluation of more than 100 known cancers.

0
+
15 years of research and development
0
+
More than 100 known cancers and leukemias can be detected
0
+
Verified through 10000+clinical samples